209 related articles for article (PubMed ID: 36493468)
1. Contingency and Entrenchment of Drug-Resistance Mutations in HIV Viral Proteins.
Choudhuri I; Biswas A; Haldane A; Levy RM
J Phys Chem B; 2022 Dec; 126(50):10622-10636. PubMed ID: 36493468
[TBL] [Abstract][Full Text] [Related]
2. Kinetic coevolutionary models predict the temporal emergence of HIV-1 resistance mutations under drug selection pressure.
Biswas A; Choudhuri I; Arnold E; Lyumkis D; Haldane A; Levy RM
Proc Natl Acad Sci U S A; 2024 Apr; 121(15):e2316662121. PubMed ID: 38557187
[TBL] [Abstract][Full Text] [Related]
3. Using machine learning and big data to explore the drug resistance landscape in HIV.
Blassel L; Tostevin A; Villabona-Arenas CJ; Peeters M; Hué S; Gascuel O;
PLoS Comput Biol; 2021 Aug; 17(8):e1008873. PubMed ID: 34437532
[TBL] [Abstract][Full Text] [Related]
4. Potential role of doravirine for the treatment of HIV-1-infected persons with transmitted drug resistance.
Rhee SY; Schapiro JM; Saladini F; Zazzi M; Khoo S; Shafer RW
AIDS Res Ther; 2023 Feb; 20(1):8. PubMed ID: 36750835
[TBL] [Abstract][Full Text] [Related]
5. Inference of Epistatic Effects Leading to Entrenchment and Drug Resistance in HIV-1 Protease.
Flynn WF; Haldane A; Torbett BE; Levy RM
Mol Biol Evol; 2017 Jun; 34(6):1291-1306. PubMed ID: 28369521
[TBL] [Abstract][Full Text] [Related]
6. Trends in HIV-1 Drug Resistance Mutations from a U.S. Reference Laboratory from 2006 to 2017.
Kagan RM; Dunn KJ; Snell GP; Nettles RE; Kaufman HW
AIDS Res Hum Retroviruses; 2019 Aug; 35(8):698-709. PubMed ID: 31169022
[TBL] [Abstract][Full Text] [Related]
7. Drug Resistance Mutation Frequency of Single-Genome Amplification-Derived HIV-1 Polymerase Genomes in the Cerebrospinal Fluid and Plasma of HIV-1-Infected Individuals under Nonsuppressive Therapy.
St Bernard L; Abolade J; Mohri H; Markowitz M; Evering TH
J Virol; 2020 Sep; 94(20):. PubMed ID: 32759323
[TBL] [Abstract][Full Text] [Related]
8. Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.
Aghokeng AF; Kouanfack C; Laurent C; Ebong E; Atem-Tambe A; Butel C; Montavon C; Mpoudi-Ngole E; Delaporte E; Peeters M
AIDS; 2011 Nov; 25(17):2183-8. PubMed ID: 21860346
[TBL] [Abstract][Full Text] [Related]
9. High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South Africa.
Etta EM; Mavhandu L; Manhaeve C; McGonigle K; Jackson P; Rekosh D; Hammarskjold ML; Bessong PO; Tebit DM
AIDS Res Ther; 2017 Jul; 14(1):36. PubMed ID: 28750647
[TBL] [Abstract][Full Text] [Related]
10. Natural polymorphisms in HIV-1 CRF01_AE strain and profile of acquired drug resistance mutations in a long-term combination treatment cohort in northeastern China.
Sun Z; Ouyang J; Zhao B; An M; Wang L; Ding H; Han X
BMC Infect Dis; 2020 Feb; 20(1):178. PubMed ID: 32102660
[TBL] [Abstract][Full Text] [Related]
11. Short communication: the number of HIV major NRTI mutations correlates directly with other antiretroviral-associated mutations and indirectly with replicative capacity and reduced drug susceptibility.
Ross L; Parkin N; Lanier R
AIDS Res Hum Retroviruses; 2008 Apr; 24(4):617-20. PubMed ID: 18366310
[TBL] [Abstract][Full Text] [Related]
12. Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States.
Ross LL; Shortino D; Shaefer MS
AIDS Res Hum Retroviruses; 2018 Aug; 34(8):672-679. PubMed ID: 29732898
[TBL] [Abstract][Full Text] [Related]
13. No Substantial Evidence for Sexual Transmission of Minority HIV Drug Resistance Mutations in Men Who Have Sex with Men.
Chaillon A; Nakazawa M; Wertheim JO; Little SJ; Smith DM; Mehta SR; Gianella S
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794047
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance mutations in HIV type 1 isolates from patients failing antiretroviral therapy in Morocco.
El Annaz H; Recordon-Pinson P; Tagajdid R; Doblali T; Belefquih B; Oumakhir S; Sedrati O; Mrani S; Fleury H
AIDS Res Hum Retroviruses; 2012 Aug; 28(8):944-8. PubMed ID: 21919803
[TBL] [Abstract][Full Text] [Related]
15. Limited evolution but increasing trends of primary non-nucleoside reverse transcriptase inhibitor resistance mutations in therapy-naive HIV-1-infected individuals in India.
Neogi U; Gupta S; Palchaudhuri R; Rao SD; Shastri S; Diwan V; Laishram RS; De Costa A; Shet A
Antivir Ther; 2014; 19(8):813-8. PubMed ID: 24699043
[TBL] [Abstract][Full Text] [Related]
16. Epistasis and entrenchment of drug resistance in HIV-1 subtype B.
Biswas A; Haldane A; Arnold E; Levy RM
Elife; 2019 Oct; 8():. PubMed ID: 31591964
[TBL] [Abstract][Full Text] [Related]
17. Archiving of mutations in HIV-1 cellular reservoirs among vertically infected adolescents is contingent with clinical stages and plasma viral load: Evidence from the EDCTP-READY study.
Fokam J; Mpouel Bala ML; Santoro MM; Takou D; Tala V; Beloumou G; Ngoufack ES; Chenwi C; Pabo Willy Leroi T; Njume D; Teto G; Dambaya B; Djupsa S; Sosso S; Ateba F; Kamta C; Bala L; Njom Nlend AE; Koki Ndombo P; Colizzi V; Perno CF; Ndjolo A
HIV Med; 2022 Jul; 23(6):629-638. PubMed ID: 34951111
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failure.
Vandenhende MA; Bellecave P; Recordon-Pinson P; Reigadas S; Bidet Y; Bruyand M; Bonnet F; Lazaro E; Neau D; Fleury H; Dabis F; Morlat P; Masquelier B
PLoS One; 2014; 9(1):e86771. PubMed ID: 24475178
[TBL] [Abstract][Full Text] [Related]
19. Major drug resistance mutations to HIV-1 protease inhibitors (PI) among patients exposed to PI class failing antiretroviral therapy in São Paulo State, Brazil.
Soldi GFR; Ribeiro IC; Ahagon CM; Coelho LPO; Cabral GB; Lopes GISL; Ferreira JLP; Brígido LFM;
PLoS One; 2019; 14(10):e0223210. PubMed ID: 31574109
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of antiretroviral drug resistance mutations in untreated young children living in the Central African Republic.
Charpentier C; Gody JC; Tisserand P; Matta M; Péré H; Fournier J; Mbitikon O; Bélec L
Antivir Ther; 2011; 16(8):1347-50. PubMed ID: 22155917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
